Afya Limited (NASDAQ:AFYA – Get Free Report) has been assigned an average rating of “Moderate Buy” from the six brokerages that are covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $18.75.
Several analysts have weighed in on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Afya in a research note on Wednesday, October 8th. UBS Group raised Afya from a “neutral” rating to a “buy” rating and reduced their target price for the stock from $19.50 to $19.00 in a report on Monday, September 8th. JPMorgan Chase & Co. upgraded Afya from a “neutral” rating to an “overweight” rating and increased their price target for the stock from $23.50 to $24.50 in a research report on Monday, September 8th. Finally, Wall Street Zen cut Afya from a “strong-buy” rating to a “buy” rating in a report on Saturday, December 20th.
Check Out Our Latest Report on Afya
Institutional Trading of Afya
Afya Stock Up 1.6%
AFYA opened at $14.95 on Wednesday. The firm has a market cap of $1.40 billion, a price-to-earnings ratio of 10.76, a PEG ratio of 0.52 and a beta of 0.52. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.98 and a current ratio of 0.98. The firm’s 50-day simple moving average is $14.65 and its 200-day simple moving average is $15.34. Afya has a twelve month low of $13.47 and a twelve month high of $19.90.
Afya Company Profile
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
See Also
- Five stocks we like better than Afya
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Do you know what Amazon is planning for January 1?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
